Health Care Products and Services
Overview
Experts
Publications

We provide economic analysis, expert testimony, and regulatory insight to support all phases of litigation pertaining to the health care industry.

Rising health care costs and growing concern over access to health care has created an environment in which producers of health care products and services face increased scrutiny of their business practices and pricing decisions. At the same time, contractual arrangements among industry participants are growing increasingly complex, and the patents that have been so important in the development of these industries face a wide array of challenges.

Economists at The Brattle Group have decades of experience working on cases involving every type of participant in these industries, including pharmaceutical manufacturers, medical device suppliers, insurers, government regulators, hospitals, physicians, pharmacy benefit managers, and others.

Brattle provides its clients with rigorous analysis while managing costs carefully in order to deliver the maximum net value to our clients. We are known for our close working relationships with leading academics and practitioners and for the clear and successful communication of economic and financial reasoning to clients, judges, juries, and other decision makers.

Areas of Expertise
Principals
Abere_068
Principal
+1.212.789.3650
Dr. Abere provides economic research, data analysis, and expert witness testimony in cases involving antitrust, contracts, intellectual property, and other commercial litigation as well as regulatory proceedings. More-icon
Borucki_113
Principal
+1.617.864.7900
Ms. Borucki is a financial economist with experience providing advice and developing expert testimony on the application of corporate finance and economics in both litigation and strategic engagements. More-icon
Cameron_063
Principal
+1.617.864.7900
Dr. Cameron has more than 15 years of experience consulting to attorneys and companies involved in commercial litigation, regulatory proceedings, and other complex matters. More-icon
Brad_johnson_web
Principal
+1.415.217.1000
Mr. Johnson has experience in litigation matters pertaining to antitrust, financial institutions, and health care. More-icon
Marin_083
Principal
+44.20.7406.7900
Dr. Marín is an expert in competition and regulation in various sectors, including energy, telecommunications, transportation, and R&D-intensive industries. More-icon
Danmcfadden557
Principal
+1.415.217.1000
Professor McFadden is a winner of the 2000 Nobel Prize in Economics, the E. Morris Cox Professor Emeritus of Economics at the University of California at Berkeley, and the founding director of its Econometrics Laboratory. More-icon
Neels_241
Principal
+1.202.955.5050
Dr. Neels has more than 30 years of research and consulting experience in all aspects of the transportation sector. More-icon
Principal
+1.202.955.5050
Dr. Reynolds is widely known for his empirical and theoretical analyses of antitrust, regulatory, and financial issues. More-icon
0185_1_
Principal
+1.202.419.3320
Dr. Simpson, a former staff economist at the Federal Trade Commission, analyzes the competitive effects of mergers, acquisitions, and various business practices in a wide range of industries. More-icon
Academic Advisors
Academic Advisor
Dr. Bowblis is an Associated Professor in the Department of Economics at Miami University, where he teaches courses in health economics, antitrust, industrial organization, econometrics, and the economics of regulation. More-icon
Academic Advisor
Dr. Grabowski is a Professor of Economics, member of the faculty for the Health Sector Management Program, and Director of the Program in Pharmaceuticals and Health Economics at Duke University. More-icon
Academic Advisor
Dr. Philipson is a Professor of Public Policy Studies at the Irving B. Harris Graduate School of Public Policy Studies at The University of Chicago, where he teaches courses in microeconomics and health economics. More-icon
Brochure
Antitrust Analysis in Physician, Hospital, and Insurer Matters
2014
Article
An empirical analysis of the multimarket contact theory in pharmaceutical markets
July 2013
Pedro L. Marín, Javier Coronado, and Sergi Jimenez-Martin
Published in The European Journal of Health Economics
Report
Preliminary Injunctions in Pharmaceutical Litigation: The Economics of Irreparable Harm
February 2011
Published by The Brattle Group, Inc.